iiinova — where your digital self keeps evolving

ClearNote Health @clearnotehealth.bsky.social · 05/11/2025

We were delighted to attend the premiere of Modì, directed by Johnny Depp and starring Al Pacino. Our team was out in force spreading awareness about the importance of early cancer detection. Learn more about the Avantect test: www.avantect.com

000

ClearNote Health @clearnotehealth.bsky.social · 04/11/2025

Our latest blog shines a light on the SAFE-D Study, the world’s largest study focused on early detection of pancreatic cancer in people newly diagnosed with type 2 diabetes. www.avantect.com/discover-the... #pancreaticcancer

000

ClearNote Health @clearnotehealth.bsky.social · 15/10/2025

Don't miss us at @myesmo.bsky.social 2025! Our team and collaborators will present new epigenomic research spanning multicancer detection, pancreatic cancer surveillance, and therapy monitoring. #epigenomics #earlycancerdetection

000

ClearNote Health @clearnotehealth.bsky.social · 25/09/2025

📢 Press Release: ClearNote Health Receives In Vitro Diagnostic Approval in United Kingdom for Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test www.clearnotehealth.com/press-releas...

000

ClearNote Health @clearnotehealth.bsky.social · 24/09/2025

✨ Today is World Cancer Research Day! Our mission to advance earlier and more accurate cancer detection is powered by a strong track record of scientific innovation and collaboration. Learn more about our work: www.clearnotehealth.com #cancerresearch #cancer

010

ClearNote Health @clearnotehealth.bsky.social · 11/09/2025

Our incredible Vice President of Laboratory Operations, Shimul Chowdhury, PhD, FACMG, recently shared a personal reflection on a career dedicated to early detection - from rapid sequencing in newborns to helping build ClearNote’s clinical lab. www.linkedin.com/pulse/era-ge... #cancer

000

ClearNote Health @clearnotehealth.bsky.social · 25/08/2025

Proud to be an expertise partner of the 15th World CB & CDx Summit Sept 22-25 | Boston, MA Meet our team at Booth #16 and discover how ClearNote Health's Virtuoso Platform is empowering more efficient oncology #drugdiscovery and development. 👉 Schedule a meeting: partnering@clearnotehealth.com

000

ClearNote Health @clearnotehealth.bsky.social · 29/07/2025

📢 Don’t miss our presentation at the 17th Annual Next Generation Summit, Aug 18-20, Washington, D.C. Talk Title: Epigenomic Signals Enable Early Cancer Detection in Liquid Biopsies When: Monday, August 18 – 9:00 am Presenter: Anna Bergamaschi, PhD, Vice President Product R&D, ClearNote Health

010

ClearNote Health @clearnotehealth.bsky.social · 21/07/2025

According to a review recently published in #JAMA, gastrointestinal cancers have become the fastest-growing type of cancers diagnosed in adults younger than 50 in the U.S. Read the article here: www.nbcnews.com/health/healt...

nbcnews.com

Gastrointestinal cancers are rising dramatically in people under 50

Some researchers suspect the trend has to do with obesity and diet. Others point to changes in the gut microbiome.

010

ClearNote Health @clearnotehealth.bsky.social · 09/07/2025

📢 We are happy to announce that ClearNote Health has received UK Conformity Assessed (UKCA) marking for its Avantect® Pancreatic Cancer Test. www.clearnotehealth.com/press-releas...

010

ClearNote Health @clearnotehealth.bsky.social · 16/06/2025

📢 Press Release: ClearNote Health Avantect® Pancreatic Cancer Test Enters Patient Enrollment Phase of Groundbreaking UK Study Targeting High-Risk Patients With up to 15,000 patient participants, it will be the largest study of its kind! www.clearnotehealth.com/press-releas... #pancreaticcancer

000

ClearNote Health @clearnotehealth.bsky.social · 09/06/2025

It was a privilege to connect with so many in the oncology community at #ASCO25. We were proud to share how our Virtuoso #epigenomics platform is redefining what’s possible for more efficient and effective #drugdevelopment. A big thank you to everyone who attended our poster presentation.

000

ClearNote Health @clearnotehealth.bsky.social · 08/05/2025

In a recently published article in Diagnostics World, our CEO Dave Mullarkey shares how a stepping-stone approach, starting with single-cancer tests targeting high-mortality cancers, can lay the groundwork for broad, multi-cancer early detection. www.diagnosticsworldnews.com/news/2025/05... #MCED

000

ClearNote Health @clearnotehealth.bsky.social · 06/05/2025

📢 Press Release: Human Longevity, Inc., Expands Cancer Prevention Offering by Selecting the ClearNote Health Avantect® Early Detection #PancreaticCancer Test. www.prnewswire.com/news-release...

000

ClearNote Health @clearnotehealth.bsky.social · 02/05/2025

Meet Our Chief Scientific Officer, Dr. Sam Levy, at #DDW25! Speak with Dr. Levy at our booth to learn how ClearNote Health is harnessing the power of the epigenome to drive early #pancreaticcancer detection and transform patient outcomes. 📍 Location: Booth 5525 📅 When: May 4th & 5th, 12:00-2:00pm

000

ClearNote Health @clearnotehealth.bsky.social · 29/04/2025

Join ClearNote Health at Digestive Disease Week (#DDW) in San Diego May 406, where we’ll be showcasing the #Avantect Pancreatic Cancer Test - a groundbreaking epigenomic liquid biopsy designed to aid in the early detection of pancreatic cancer. Visit us at booth 5525

000

ClearNote Health @clearnotehealth.bsky.social · 28/04/2025

Last week, we proudly celebrated National Medical Laboratory Professionals Week at ClearNote Health! 🎉 A huge thank you to our tremendous laboratory team for their on-going commitment and dedication to our mission of saving lives through earlier detection of cancer. #LabWeek

000

ClearNote Health @clearnotehealth.bsky.social · 09/04/2025

📢 We will be at the @theaacr.bsky.social Annual Meeting '25, 25-30/04, Chicago. Discover how our Virtuoso Epigenomics Platform is empowering more efficient oncology #drugdiscovery & development by leveraging 5hmC #epigenomic profiling to uncover active cancer biology patterns from #cfDNA in plasma.

012